106 related articles for article (PubMed ID: 32032260)
21. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma.
Bronkhorst IH; Maat W; Jordanova ES; Kroes WG; Schalij-Delfos NE; Luyten GP; Jager MJ
Arch Pathol Lab Med; 2011 Aug; 135(8):1042-7. PubMed ID: 21809997
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
[TBL] [Abstract][Full Text] [Related]
23. [Uveal melanoma: clinical characteristics, treatment and survival in a series of 500 patients].
Vicente N; Saornil MA; García-Álvarez C; Almaraz A; Alonso Martínez P; Frutos-Baraja JM; López-Lara F
Arch Soc Esp Oftalmol; 2013 Nov; 88(11):433-8. PubMed ID: 24157321
[TBL] [Abstract][Full Text] [Related]
24. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases.
Shields CL; Kaliki S; Furuta M; Mashayekhi A; Shields JA
Retina; 2012 Jul; 32(7):1363-72. PubMed ID: 22466491
[TBL] [Abstract][Full Text] [Related]
25. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
Coupland SE; Campbell I; Damato B
Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
[TBL] [Abstract][Full Text] [Related]
26. Nondiagnosed uveal melanomas.
Bove R; Char DH
Ophthalmology; 2004 Mar; 111(3):554-7. PubMed ID: 15019335
[TBL] [Abstract][Full Text] [Related]
27. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma.
Kroll S; Char DH; Quivey J; Castro J
Ophthalmology; 1998 Nov; 105(11):2035-45. PubMed ID: 9818602
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity of 1p in uveal melanomas with monosomy 3.
Häusler T; Stang A; Anastassiou G; Jöckel KH; Mrzyk S; Horsthemke B; Lohmann DR; Zeschnigk M
Int J Cancer; 2005 Oct; 116(6):909-13. PubMed ID: 15849744
[TBL] [Abstract][Full Text] [Related]
29. Clinical predictors of survival in metastatic uveal melanoma.
Lorenzo D; Piulats JM; Ochoa M; Arias L; Gutiérrez C; Català J; Cobos E; Garcia-Bru P; Dias B; Padrón-Pérez N; Caminal JM
Jpn J Ophthalmol; 2019 Mar; 63(2):197-209. PubMed ID: 30796549
[TBL] [Abstract][Full Text] [Related]
30. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.
van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574
[TBL] [Abstract][Full Text] [Related]
31. Clinical Features, Metastasis, and Survival in Patients Younger Than 21 Years With Posterior Uveal Melanoma.
Fry MV; Augsburger JJ; Corrêa ZM
JAMA Ophthalmol; 2019 Jan; 137(1):75-81. PubMed ID: 30422230
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Metastatic Risk after Biopsy of Posterior Uveal Melanoma.
Bagger M; Smidt-Nielsen I; Andersen MK; Jensen PK; Heegaard S; Andersen KK; Friis S; Kiilgaard JF
Ophthalmology; 2018 Dec; 125(12):1969-1976. PubMed ID: 29705056
[TBL] [Abstract][Full Text] [Related]
33. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.
Lane AM; Kim IK; Gragoudas ES
JAMA Ophthalmol; 2015 Jul; 133(7):792-6. PubMed ID: 25905597
[TBL] [Abstract][Full Text] [Related]
34. Detection of uveal melanoma by optometrists in the United Kingdom.
Damato B
Ophthalmic Physiol Opt; 2001 Jul; 21(4):268-71. PubMed ID: 11430620
[TBL] [Abstract][Full Text] [Related]
35. External Validation of the Liverpool Uveal Melanoma Prognosticator Online.
DeParis SW; Taktak A; Eleuteri A; Enanoria W; Heimann H; Coupland SE; Damato B
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6116-6122. PubMed ID: 27835710
[TBL] [Abstract][Full Text] [Related]
36. Uveal melanoma in the first 4 decades of life.
Sagus M; Bedikian AY
South Med J; 2015 Mar; 108(3):158-63. PubMed ID: 25772049
[TBL] [Abstract][Full Text] [Related]
37. Molecular prognostic testing and individualized patient care in uveal melanoma.
Harbour JW
Am J Ophthalmol; 2009 Dec; 148(6):823-9.e1. PubMed ID: 19800609
[TBL] [Abstract][Full Text] [Related]
38. Digital morphometry of tumor nuclei correlates to BAP-1 status, monosomy 3, gene expression class and survival in uveal melanoma.
Herrspiegel C; See TRO; Mendoza PR; Grossniklaus HE; Stålhammar G
Exp Eye Res; 2020 Apr; 193():107987. PubMed ID: 32097618
[TBL] [Abstract][Full Text] [Related]
39. Clinical and cytogenetic analyses in uveal melanoma.
Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A
BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
